Covered recipient · General Payments record
RICHARD AGUILAR
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2023
$338,674.85
- Reported across 432 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $8,568.75 | 2 |
| Travel and Lodging | $1,526.02 | 5 |
| Food and Beverage | $362.68 | 5 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $6,172.98 | 4 |
| Genentech, Inc. | $4,207.94 | 6 |
| BOSTON SCIENTIFIC CORPORATION | $58.05 | 1 |
| Abbott Laboratories | $18.48 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $18.48 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019276139 | CMS |
| Boston Scientific Corporation | $58.05 | 09/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022309361 | CMS |
| Genentech, Inc. | $134.99 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040519079 | CMS |
| Genentech, Inc. | $48.71 | 06/16/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1040519089 | CMS |
| Genentech, Inc. | $73.80 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040519095 | CMS |
| Genentech, Inc. | $2,850.00 | 06/16/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1040519105 | CMS |
| Genentech, Inc. | $849.59 | 06/16/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1040519111 | CMS |
| Genentech, Inc. | $250.85 | 06/16/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1040519119 | CMS |
| Novo Nordisk Inc | $77.36 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000200409 | CMS |
| Novo Nordisk Inc | $165.80 | 04/20/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1000200417 | CMS |
| Novo Nordisk Inc | $211.07 | 04/20/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1000200423 | CMS |
| Novo Nordisk Inc | $5,718.75 | 04/20/2023 | Consulting Fee | Undisputed | 01/23/2026 | 1000200431 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.